USP18 Activators

USP18, or Ubiquitin-specific protease 18, serves as a key regulator in the innate immune system, particularly in the context of interferon (IFN) signaling pathways. Its primary function revolves around the negative regulation of type I interferon (IFN-I) signaling, a crucial aspect of the host immune response against viral infections. Upon viral infection or other immune stimuli, cells produce IFN-I, which activates a cascade of signaling events leading to the expression of interferon-stimulated genes (ISGs) involved in antiviral defense mechanisms. USP18 modulates this response by deconjugating the ubiquitin-like protein ISG15 from target proteins, a process known as deISGylation. This action attenuates the antiviral effects of IFN-I signaling by dampening the ISG15ylation of target proteins, thus providing a negative feedback loop to regulate the intensity and duration of the immune response.

Activation of USP18 occurs in response to IFN-I stimulation, whereby increased levels of IFN-I induce the expression and enzymatic activity of USP18. Upon binding to its cognate receptors on the cell surface, IFN-I triggers a signaling cascade that ultimately leads to the activation of transcription factors, such as STAT1 and STAT2, which translocate to the nucleus and promote the expression of ISGs, including USP18. Once expressed, USP18 acts to negatively regulate IFN-I signaling by deconjugating ISG15 from target proteins, thereby suppressing the antiviral response. Additionally, USP18 activation may also be modulated by post-translational modifications or protein-protein interactions, which further fine-tune its enzymatic activity and cellular functions in response to immune stimuli. Overall, the activation of USP18 represents a critical mechanism for regulating the intensity and duration of the innate immune response to viral infections and other pathogens.